Mariana Chávez‐MacGregor

14.0k total citations · 5 hit papers
180 papers, 8.7k citations indexed

About

Mariana Chávez‐MacGregor is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mariana Chávez‐MacGregor has authored 180 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Oncology, 95 papers in Cancer Research and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mariana Chávez‐MacGregor's work include Breast Cancer Treatment Studies (90 papers), HER2/EGFR in Cancer Research (38 papers) and Global Cancer Incidence and Screening (29 papers). Mariana Chávez‐MacGregor is often cited by papers focused on Breast Cancer Treatment Studies (90 papers), HER2/EGFR in Cancer Research (38 papers) and Global Cancer Incidence and Screening (29 papers). Mariana Chávez‐MacGregor collaborates with scholars based in United States, United Kingdom and Australia. Mariana Chávez‐MacGregor's co-authors include Sharon H. Giordano, Gabriel N. Hortobágyi, Xiudong Lei, Janet K. Horton, Vicente Valero, Meena S. Moran, Monica Morrow, Nehmat Houssami, Jay R. Harris and Stuart J. Schnitt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mariana Chávez‐MacGregor

168 papers receiving 8.6k citations

Hit Papers

Estrogen and Progesterone Receptor Testing ... 2014 2026 2018 2022 2020 2016 2014 2022 2024 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
    2020 851 citations Kimberly H. Allison, Mariana Chávez‐MacGregor et al. Journal of Clinical Oncology profile →
  2. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection
    2016 578 citations Abigail S. Caudle, Savitri Krishnamurthy et al. Journal of Clinical Oncology profile →
  3. Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
    2014 451 citations Meena S. Moran, Stuart J. Schnitt et al. Annals of Surgical Oncology profile →
  4. Overall survival (OS) with first-line palbociclib plus letrozole (PAL+LET) versus placebo plus letrozole (PBO+LET) in women with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer (ER+/HER2− ABC): Analyses from PALOMA-2.
    2022 109 citations Hope S. Rugo, Mariana Chávez‐MacGregor et al. Journal of Clinical Oncology profile →
  5. Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
    2024 81 citations Hope S. Rugo, Mariana Chávez‐MacGregor et al. Journal of Clinical Oncology profile →

Peers

Mariana Chávez‐MacGregor
Nicole Rotmensz Italy
Anthony Lucci United States
Kristine Broglio United States
Vivianne C. G. Tjan‐Heijnen Netherlands
Gerrit‐Jan Liefers Netherlands
Carien L. Creutzberg Netherlands
Bernard Asselain France
Isabelle Bedrosian United States
Jens‐Uwe Blohmer Germany
Wolfgang Janni Germany
Nicole Rotmensz Italy
Mariana Chávez‐MacGregor
Citations per year, relative to Mariana Chávez‐MacGregor Mariana Chávez‐MacGregor (= 1×) peers Nicole Rotmensz

Countries citing papers authored by Mariana Chávez‐MacGregor

Since Specialization
Citations

This map shows the geographic impact of Mariana Chávez‐MacGregor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariana Chávez‐MacGregor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariana Chávez‐MacGregor more than expected).

Fields of papers citing papers by Mariana Chávez‐MacGregor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariana Chávez‐MacGregor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariana Chávez‐MacGregor. The network helps show where Mariana Chávez‐MacGregor may publish in the future.

Co-authorship network of co-authors of Mariana Chávez‐MacGregor

This figure shows the co-authorship network connecting the top 25 collaborators of Mariana Chávez‐MacGregor. A scholar is included among the top collaborators of Mariana Chávez‐MacGregor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariana Chávez‐MacGregor. Mariana Chávez‐MacGregor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winchester, David J., Stephen B. Edge, Kimberly H. Allison, et al.. (2025). Novel Postneoadjuvant Prognostic Breast Cancer Staging System. Journal of Clinical Oncology. 43(17). 1948–1960. 3 indexed citations
2.
Winer, Eric P., Laura A. Levit, Ethan Basch, et al.. (2025). Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers. Journal of Clinical Oncology. 43(17). 2017–2023. 2 indexed citations
3.
4.
5.
6.
Freedman, Rachel A., Jennifer L. Caswell‐Jin, Michael J. Hassett, et al.. (2024). Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer—Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology. 42(18). 2233–2235. 18 indexed citations
7.
Milbury, Kathrin, Morgan H. Jones, Yisheng Li, et al.. (2024). Patients with advanced cancer and their spouses parenting minor children: The role of the relationship context in parenting concerns. Psycho-Oncology. 33(3). e6310–e6310. 8 indexed citations
8.
Al‐Sukhun, Sana, Sarah Temin, Carlos H. Barrios, et al.. (2024). Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource–Stratified Guideline. JCO Global Oncology. 10(10). e2300285–e2300285. 25 indexed citations
9.
Glass, Charity C., Rachel A. Freedman, Erica L. Mayer, et al.. (2023). Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I–III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical Trial. Annals of Surgical Oncology. 30(13). 8320–8326.
10.
Bruera, Sebastian, Xiudong Lei, Hui Zhao, et al.. (2023). Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus. Lupus Science & Medicine. 10(1). e000750–e000750. 12 indexed citations
11.
Chávez‐MacGregor, Mariana, et al.. (2023). Medicaid expansion, chemotherapy delays, and racial disparities among women with early-stage breast cancer. JNCI Journal of the National Cancer Institute. 115(6). 644–651. 10 indexed citations
12.
Spence, Rebecca, Leslie Hinyard, Reshma Jagsi, et al.. (2023). ASCO Ethical Guidance for the US Oncology Community Where Reproductive Health Care Is Limited by Law. Journal of Clinical Oncology. 41(15). 2852–2858. 3 indexed citations
13.
Cacho‐Díaz, Bernardo, et al.. (2020). Identification of risk factors for central nervous system metastasis in patients with breast cancer with neurologic symptoms. Cancer. 126(15). 3456–3463. 2 indexed citations
14.
Denduluri, Neelima, Mark R. Somerfield, Mariana Chávez‐MacGregor, et al.. (2020). Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 39(6). 685–693. 76 indexed citations
15.
Lim, Bora, Juhee Song, Nuhad K. Ibrahim, et al.. (2020). A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer. The Oncologist. 26(2). e230–e240. 5 indexed citations
16.
Mittendorf, Elizabeth A., Mariana Chávez‐MacGregor, José Vila, et al.. (2017). Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology. Annals of Surgical Oncology. 24(12). 3502–3509. 36 indexed citations
17.
González-Angulo, Ana M., Napa Parinyanitikul, Xiudong Lei, et al.. (2015). Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy. British Journal of Cancer. 112(4). 630–635. 10 indexed citations
18.
19.
Moran, Meena S., Stuart J. Schnitt, Armando E. Giuliano, et al.. (2014). Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer. Journal of Clinical Oncology. 32(14). 1507–1515. 285 indexed citations
20.
Chávez‐MacGregor, Mariana & Ana M. González-Angulo. (2009). HER2-neu positivity in patients with small and node-negative breast cancer (pT1a,b,N0,M0): a high risk group?. PubMed. 7(9). 591–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Rotmensz Breakdown of academic impact, for papers by Anthony Lucci Breakdown of academic impact, for papers by Kristine Broglio Breakdown of academic impact, for papers by Vivianne C. G. Tjan‐Heijnen Breakdown of academic impact, for papers by Gerrit‐Jan Liefers Breakdown of academic impact, for papers by Carien L. Creutzberg Breakdown of academic impact, for papers by Bernard Asselain Breakdown of academic impact, for papers by Isabelle Bedrosian Breakdown of academic impact, for papers by Jens‐Uwe Blohmer Breakdown of academic impact, for papers by Wolfgang Janni
Rankless by CCL
2026